Scania Diabetes Registry
SND-ID: ext0074-1.
Is part of collection at SND: Scania Metadatabase for Epidemiology (SME)
Access to data via
Contact
Leif Groop
Associated documentation
Creator/Principal investigator(s)
Leif Groop - Lunds universitet, Institutionen för kliniska vetenskaper, avdelningen för diabetes och endokrinologi
Carl-David Agardh - Lunds universitet, Institutionen för kliniska vetenskaper, avdelningen för diabetes och endokrinologi
Eeron Lindholm - Lunds universitet/Malmö, Sektionen för barn/urologi/kvinnosjukvård/endokrinologi/Kliniska vetenskaper
Research principal
Lund University
- Department of Clinical Sciences
Description
The Scania Diabetes Registry contains over 7000 diabetes patients recruited at hospitals in Scania, Sweden as from 1996. The majority of the patients come from the city of Malmö, and they account for about 25% of all diabetic patients in the region. At the clinic, all patients with Diabetes Mellitus were asked if they would like to participate in Scania Diabetes Registry. The diagnosis of the diabetes was made in the clinic, and the majority of patients were on antidiabetic treatment. Additional information has been added from the routinely clinical follow-ups.
Information about onset of diabetes, and mode of treatment, BMI, HbA1C, creatinine, lipids, albumin excretion rate (AER) as well as smoking habits was obtained from patient records. In addition, blood samples were obtained for measurement of C-peptide, GAD antibodies and for DNA. Follow-up information on metabolic control, progression of disease, development of diabetic complications is obtained from patient records. Information includes retinopathy, nephropathy, neuropathy and macrovascular diseases.
Purpose:
To 1) Create a dat
Information about onset of diabetes, and mode of treatment, BMI, HbA1C, creatinine, lipids, albumin excretion rate (AER) as well as smoking habits was obtained from patient records. In addition, blood samples were obtained for measurement of C-peptide, GAD antibodies and for DNA. Follow-up information on metabolic control, progression of disease, development of diabetic complications is obtained from patient records. Information includes retinopathy, nephropathy, neuropathy and macrovascular diseases.
Purpose:
To 1) Create a databank and bio-bank of all available diabetic patients in Scania to allow more precise classification of diabetic subgroups, 2) identify genetic variants predisposing to micro and macrovascular complications 3) study how the identified biomarkers and genetic markers can predict development and progression of complications and 4) identify means to prevent the development of these complications. Show less..
Unit of analysis
Time period(s) investigated
1996 – Ongoing
Number of individuals/objects
7400
Data format / data structure
Geographic spread
Geographic description: Scania
Responsible department/unit
Department of Clinical Sciences
Research area
Medical and health sciences (Standard för svensk indelning av forskningsämnen 2011)
Clinical medicine (Standard för svensk indelning av forskningsämnen 2011)
Endocrinology and diabetes (Standard för svensk indelning av forskningsämnen 2011)
Health (CESSDA Topic Classification)